Showing results (71-80 of 190) with videos related to
Sort By:
Pageof 19
Cancer Immunology Research|May 7, 2015
Single Institution Experience of Ipilimumab 3 mg/kg with Sargramostim (GM-CSF) in Metastatic MelanomaJason J Luke, Hilary Donahue, Mizuki Nishino, et al.Journal for Immunotherapy of Cancer|November 10, 2019
Secondary resistance to immunotherapy associated with β-catenin pathway activation or PTEN loss in metastatic melanomaJonathan A Trujillo, Jason J Luke, Yuanyuan Zha, et al.American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|April 15, 2025
Beyond Checkpoint Inhibition: Keeping Therapeutic Options OpenUrvashi Mitbander Joshi, Jasmin Hundal, Jonaphine R Mata, et al.Journal of the National Cancer Institute|August 10, 2014
Realizing the potential of plasma genotyping in an age of genotype-directed therapiesJason J Luke, Geoffrey R Oxnard, Cloud P Paweletz, et al.Cancer Medicine|August 6, 2022
Multiple primary melanoma in association with other personal and familial cancersXi Yang, Lilit Karapetyan, Ziyu Huang, et al.Proceedings of the National Academy of Sciences of the United States of America|November 13, 2016
Density of immunogenic antigens does not explain the presence or absence of the T-cell-inflamed tumor microenvironment in melanomaStefani Spranger, Jason J Luke, Riyue Bao, et al.Cancer Chemotherapy and Pharmacology|January 27, 2016
ASP9853, an inhibitor of inducible nitric oxide synthase dimerization, in combination with docetaxel: preclinical investigation and a Phase I study in advanced solid tumorsJason J Luke, Patricia LoRusso, Geoffrey I Shapiro, et al.Oncotarget|February 14, 2018
Clinical and molecular features of innate and acquired resistance to anti-PD-1/PD-L1 therapy in lung cancerShalin Shah, Kevin Wood, Brian Labadie, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 25, 2014
Systemic high-dose corticosteroid treatment does not improve the outcome of ipilimumab-related hypophysitis: a retrospective cohort studyLe Min, Frank Stephen Hodi, Anita Giobbie-Hurder, et al.Journal for Immunotherapy of Cancer|July 17, 2021
Immunogenomic determinants of tumor microenvironment correlate with superior survival in high-risk neuroblastomaRiyue Bao, Stefani Spranger, Kyle Hernandez, et al.Pageof 19